Veterinary Medicines

Diurizone Injectable

Authorised
  • Dexamethasone
  • Hydrochlorothiazide
Download as PDF

Product identification

Medicine name:
Diurizone Injectable
Active substance:
  • Dexamethasone
  • Hydrochlorothiazide
Target species:
  • Cattle
  • Horse (non food-producing)
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Dexamethasone
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Hydrochlorothiazide
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        7
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        7
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03AX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 50 ml amber type II glass vial closed with chlorobutyl stopper and sealed with an aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Ireland Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10983/011/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download